CXC-Chemokine Receptor 4 Antagonist AMD3100 Promotes Cardiac Functional Recovery After Ischemia/Reperfusion Injury via Endothelial Nitric Oxide Synthase–Dependent Mechanism - Concepedia

Concepedia

Publication | Open Access

CXC-Chemokine Receptor 4 Antagonist AMD3100 Promotes Cardiac Functional Recovery After Ischemia/Reperfusion Injury via Endothelial Nitric Oxide Synthase–Dependent Mechanism

DOI Full Paper Access

94

Citations

38

References

2012

Year

Kentaro Jujo, Masaaki Ii, Haruki Sekiguchi, Ekaterina Klyachko, Sol Misener, Toshikazu Tanaka, Jörn Tongers, Jérôme Roncalli, Marie‐Ange Renault, Tina Thorne,

Abstract

AMD3100 prolongs BM progenitor mobilization and improves recovery from ischemia/reperfusion injury, and these benefits appear to occur through a previously unidentified link between AMD3100 and BM eNOS expression.

References

	Year	Citations

Page 1